Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis

American Journal of Pathology

Volumn 151, Issue 4, 1997, Pages 897-904

  Stahel, Philip F ^a   Frei, Karl ^b   Fontana, Adriano ^b   Eugster, Hans Pietro ^b   Ault, Bettina H ^c   Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; FEMALE; LISTERIA MONOCYTOGENES; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN; COMPLEMENT C3; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; FEMALE; GENE EXPRESSION REGULATION; LEUKOCYTES; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MENINGITIS, BACTERIAL; MICE; NEURONS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030759952     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Quagliarello VJ, Scheld WM: Treatment of bacterial meningitis. N Engl J Med 1997, 336:708-716
2. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN: Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993, 328:21-28
3. Quagliarello V, Scheld WM: Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992, 327:864-872
4. Townsend GC, Scheld WM: Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clin Infect Dis 1993, 17:S537-S549
5. Pfister H-W, Fontana A, Täuber MG, Tomasz A, Scheld WM: Mechanisms of brain injury in bacterial meningitis: Workshop summary. Clin Infect Dis 1994, 19:463-479
6. Townsend GC, Scheld WM: The use of corticosteroids in the management of bacterial meningitis in adults. J Antimicrob Chemother 1996, 37:1051-1061
7. Täuber MG, Borschberg U, Sande MA: Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis 1988, 157:456-464
8. Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD: Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 1989, 170:959-968
9. Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E: The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990, 171:439-448
10. Saez-Llorens X, Jafari HS, Severien C, Parras F, Olsen KD, Hansen EJ, Singer II, McCracken GH Jr: Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J Clin Invest 1991, 88:2003-2011
11. Tang T, Frenette PS, Hynes RO, Wagner DD, Mayadas TN: Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J Clin Invest 1996, 97:2485-2490
12. Seebach J, Bartholdi D, Frei K, Spanaus K-S, Ferrero E, Widmer U, Isenmann S, Strieter RM, Schwab M, Pfister H-W, Fontana A: Experimental Listeria meningoencephalitis: macrophage inflammatory protein-1α and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J Immunol 1995, 155:4367-4375
13. Spanaus K-S, Nadal D, Pfister H-W, Seebach J, Widmer U, Frei K, Gloor S, Fontana A: C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol 1997, 158:1956-1964
14. Ernst JD, Hartiala KT, Goldstein IM, Sande AM: Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect Immun 1984, 46:81-86
15. Tuomanen E, Hengstler B, Zak O, Tomasz A: The role of complement in inflammation during experimental pneumococcal meningitis. Microb Pathog 1986, 1:15-32
16. Kadurugamuwa JL, Hengstler B, Bray MA, Zak O: Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis. J Infect Dis 1989, 160:715-719
17. Faustmann PM, Krause D, Dux R, Dermietzel R: Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol 1995, 89:239-247
18. Stahel PF, Frei K, Eugster H-P, Fontana A, Hummel KM, Wetsel RA, Ames RS, Barnum SR: TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J Immunol 1997, 159:861-869
19. Stahel PF, Nadal D, Pfister H-W, Paradisis PM, Barnum SR: Complement C3 and factor B cerebrospinal fluid levels in bacterial and aseptic meningitis. Lancet 1997, 349:1886-1887
20. Zwahlen A, Nydegger UE, Vaudaux P, Lambert P-H, Waldvogel FA: Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis 1982, 145:635-646
21. Boje K: Cerebrovascular permeability changes during experimental meningitis in the rat. J Pharmacol Exp Ther 1995, 274:1199-1203
22. Dujardin BCG, Driedijk PC, Roijers AFM, Out TA: The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay. J Immunol Methods 1985, 80:227-237
23. Kossmann T, Stahel PF, Morganti-Kossmann MC, Jones JL, Barnum SR: Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury. J Neuroimmunol 1997, 73:63-69
24. Barnum SR: Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 1995, 6:132-146
25. Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A: Tumor necrosis factor α in cerebrospinal fluid during bacterial, but not viral meningitis: evaluation in murine model infections and in patients. J Exp Med 1988, 167:1743-1748
26. Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A: Tumour necrosis factor-α in infectious meningitis. Arch Dis Child 1989, 64: 1274-1279
27. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T: Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis: relation to the inflammatory response. J Exp Med 1989, 170:1859-1867
28. Frei K, Nadal D, Pfister H-W, Fontana A: Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med 1993, 178:1255-1261
29. Eugster H-P, Müller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B: Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int Immunol 1996, 8:23-36
30. Roth J, Saremaslani P, Warhol MJ, Heitz PU: Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensification. Lab Invest 1992, 67:263-269
31. Ishikawa N, Nonaka M, Wetsel RA, Colten HR: Murine complement C2 and factor B genomic and cDNA cloning reveals different mechanisms for multiple transcripts of C2 and B. J Biol Chem 1990, 265:19040-19046
32. Ault BH, Colten HR: Cellular specificity of murine renal C3 expression in two models of inflammation. Immunology 1994, 81:655-660
33. Wetsel RA, Lundwall A, Davidson F, Gibson T, Tack BF, Fey GH: Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the a chain. J Biol Chem 1984, 259:13857-13862
34. Bitter-Suermann D, Burger R, Brade V, Hadding U: Mouse factor B of the alternative pathway of complement activation. I. Purification, characterization and functional behaviour. J Immunol 1976, 117:1799-1804
35. Fothergill LD: Observations on the presence of complement in the cerebrospinal fluid in various pathologic conditions of the central nervous system. J Pediatr 1935, 6:374-381
36. Stahel PF, Barnum SR: Bacterial meningitis: complement gene expression in the central nervous system. Immunopharmacology 1997 (in press)
37. Rozovsky I, Morgan TE, Willoughby DA, Dugich-Djordjevich MM, Pasinetti GM, Johnson SA, Finch CE: Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 1994, 62:741-758
38. Barnum SR, Jones JL, Müller-Ladner U, Samimi A, Campbell IL: Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 1996, 18: 107-117
39. Gutierrez EG, Banks WA, Kastin AJ: Murine tumor necrosis factor α is transported from blood to brain in the mouse. J Neuroimmunol 1993, 47:169-176